Quent Capital LLC Sells 906 Shares of CVS Health Co. (NYSE:CVS)

Quent Capital LLC lessened its holdings in CVS Health Co. (NYSE:CVS) by 30.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,029 shares of the pharmacy operator’s stock after selling 906 shares during the period. Quent Capital LLC’s holdings in CVS Health were worth $91,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of CVS. MidAtlantic Capital Management Inc. bought a new position in CVS Health in the third quarter valued at about $25,000. Ridgewood Investments LLC boosted its stake in shares of CVS Health by 255.7% during the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 450 shares in the last quarter. Stonebridge Financial Group LLC acquired a new stake in shares of CVS Health during the fourth quarter valued at about $28,000. Livelsberger Financial Advisory acquired a new stake in shares of CVS Health during the third quarter valued at about $31,000. Finally, Legacy Investment Solutions LLC acquired a new stake in shares of CVS Health during the third quarter valued at about $31,000. Institutional investors own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

CVS has been the topic of a number of recent research reports. Piper Sandler cut their price target on CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a research note on Monday, November 25th. Leerink Partners lifted their price target on CVS Health from $51.00 to $55.00 and gave the company a “market perform” rating in a research note on Tuesday. Barclays cut their price target on CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a research note on Thursday, November 7th. UBS Group cut their price objective on CVS Health from $62.00 to $59.00 and set a “neutral” rating on the stock in a research note on Tuesday. Finally, TD Cowen lifted their price objective on CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research note on Monday, November 25th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the company. According to MarketBeat, CVS Health currently has an average rating of “Moderate Buy” and a consensus price target of $67.78.

CVS Health Trading Up 15.0 %

NYSE CVS opened at $63.23 on Thursday. The company has a market cap of $79.57 billion, a price-to-earnings ratio of 16.05, a P/E/G ratio of 0.60 and a beta of 0.61. CVS Health Co. has a 52 week low of $43.56 and a 52 week high of $80.75. The business has a 50 day moving average price of $50.61 and a 200-day moving average price of $55.92. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, beating the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. As a group, equities analysts expect that CVS Health Co. will post 5.14 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were issued a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, January 23rd. This represents a $2.66 annualized dividend and a dividend yield of 4.21%. CVS Health’s dividend payout ratio is 67.51%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.